EUVIMEDEUVIMED entdecken
Crossref

Impact of Growth Factors and Bone Age on BMD in Children and Adolescents With Cerebral Palsy

Marianne Lindblad Pedersen iD, Reem Zaabalawi iD, Nanette Mol Debes, Christina Engel Hoei-Hansen, Jesper Johannesen iD

Acta Paediatrica · 2026

DOI: 10.1111/apa.70405 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Paediatrica, 2026. Verfasst von Marianne Lindblad Pedersen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University Hospital Herlev, Herlev, Denmark. Hauptthemen laut MEDLINE: Cerebral Palsy, Bone Density, Insulin-Like Growth Factor I, Insulin-Like Growth Factor Binding Protein 3. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Elsass Fonden, Dagmar Marshalls Fond, the Dronning Louises Børnehospitals Fond.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Children with cerebral palsy (CP) have reduced bone mineral density (BMD) and increased risk of fragility fracture. Despite the critical role in skeletal development, no studies have examined insulin‐like growth factor‐1 (IGF‐1) and insulin‐like growth factor binding protein‐ 3 (IGFBP‐3), and their association with BMD in children with CP when adjusted for bone age. This study assesses the relationship between IGF‐1 and IGFBP‐3 and BMD in children with CP while accounting for bone age adjustment.

Methods

Cross‐sectional study, 81 children with CP GMFCS I–V, aged 2–17 years (55.6% males), underwent clinical examination, DXA scan, blood sampling and bone age assessment. Regression analysis assessed associations between IGF‐1, IGFBP‐3 and BMD.

Results

Bone age was 0.64 years lower than chronological age ( p < 0.05). Adjusted for bone age, BMD showed a positive association with IGF‐1 ( p < 0.05) and IGFBP‐3 ( p < 0.05). BMD z ‐score negatively associated with CP severity ( p < 0.05) and CP severity was negatively associated with IGF‐1 ( p < 0.5) and IGFBP‐3 ( p < 0.05).

Conclusion

Children with CP had lower bone age than chronological age. BMD was positively associated with IGF‐1 and IGFBP‐3 adjusted for bone age. These findings are useful in growth hormone and osteoporosis treatment, such as Zoledronate, in CP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebral PalsyBone DensityInsulin-Like Growth Factor IInsulin-Like Growth Factor Binding Protein 3HumansChildMaleAdolescentFemaleCross-Sectional StudiesChild, PreschoolAge Determination by Skeleton

Stichwörter der Autor:innen

bone agebone mineral densitycerebral palsyinsulin‐like growth factor‐1insulin‐like growth factor‐binding protein 3

Substanzen

Insulin-Like Growth Factor IInsulin-Like Growth Factor Binding Protein 3IGFBP3 protein, human

Autor:innen und Institutionen

  • Department of Pediatrics, University Hospital Herlev, Herlev, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Department of Pediatrics, University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Steno Diabetes Center Copenhagen, Herlev, Denmark.

ORCID-Profile: Marianne Lindblad Pedersen, Reem Zaabalawi, Jesper Johannesen

Förderung

  • Elsass Fonden
  • Dagmar Marshalls Fond
  • the Dronning Louises Børnehospitals Fond

Zitieren

APA

Pedersen, M. L., Zaabalawi, R., Debes, N. M., Hoei-Hansen, C. E., & Johannesen, J. (2026). Impact of Growth Factors and Bone Age on BMD in Children and Adolescents With Cerebral Palsy. Acta Paediatrica. https://doi.org/10.1111/apa.70405

Vancouver

Pedersen ML, Zaabalawi R, Debes NM, Hoei-Hansen CE, Johannesen J. Impact of Growth Factors and Bone Age on BMD in Children and Adolescents With Cerebral Palsy. Acta Paediatrica. 2026. doi:10.1111/apa.70405

BibTeX
@article{Pedersen2026,
  author = {Pedersen, Marianne Lindblad and Zaabalawi, Reem and Debes, Nanette Mol and Hoei-Hansen, Christina Engel and Johannesen, Jesper},
  title = {Impact of Growth Factors and Bone Age on BMD in Children and Adolescents With Cerebral Palsy},
  journal = {Acta Paediatrica},
  year = {2026},
  doi = {10.1111/apa.70405}
}
Kostenlos starten →